Baird Assumes Homology Medicines (FIXX) at Outperform

June 2, 2022 4:18 PM EDT
Get Alerts FIXX Hot Sheet
Price: $1.56 --0%

Rating Summary:
    8 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 7
Join SI Premium – FREE

Baird analyst Jack Allen assumes coverage on Homology Medicines (NASDAQ: FIXX) with a Outperform rating and a price target of $10.00.

For an analyst ratings summary and ratings history on Homology Medicines click here. For more ratings news on Homology Medicines click here.

Shares of Homology Medicines closed at $1.45 yesterday.

You May Also Be Interested In

Related Categories

New Coverage